Silvia Ottaviani

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 12

Top Venues

Polymer chemistry

Nature communications

Journal of neurology

Cancer research

Imperial College London

Imperial College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Imperial College London

United Kingdom

Research Associate :: Division of Cancer

Imperial College London

United Kingdom

Research Assistant :: Division of Cancer

Education History

Imperial College London

United Kingdom

PHD :: Division of Cancer

Imperial College London

United Kingdom

MSC :: Faculty of Medicine

Vita-Salute San Raffaele University

Italy

BSC :: Faculty of Medicine

Publications

Joana S Correia, Sofía Mirón-Barroso, Charlotte Hutchings, Silvia Ottaviani, Birsen Somuncuoğlu, Leandro Castellano, Alexandra E Porter, Jonathan Krell, Theoni K Georgiou
How does the polymer architecture and position of cationic charges affect cell viability? Polymer chemistry 14 (3) (2022)
Joana S Correia, Sofía Mirón-Barroso, Charlotte Hutchings, Silvia Ottaviani, Birsen Somuncuoğlu, Leandro Castellano, Alexandra E Porter, Jonathan Krell, Theoni K Georgiou
How does the polymer architecture and position of cationic charges affect cell viability? Polymer chemistry 14 (3) (2022)
Sofía Mirón-Barroso, Joana S Correia, Adam Enver Frampton, Mark P Lythgoe, James Clark, Laura Tookman, Silvia Ottaviani, Castellano L, Alexandra E Porter, Theoni K Georgiou, Jonathan Krell
Polymeric Carriers for Delivery of RNA Cancer Therapeutics. Non-coding RNA 8 (4) (2022)
Justin Stebbing, Ginés Sánchez Nievas, Marco Falcone, Sonia Youhanna, Peter Richardson, Silvia Ottaviani, Joanne X Shen, Christian Sommerauer, Giusy Tiseo, Lorenzo Ghiadoni, Agostino Virdis, Fabio Monzani, Luis Romero Rizos, Francesco Forfori, Almudena Avendaño Céspedes, Salvatore De Marco, Laura Carrozzi, Fabio Lena, Pedro Manuel Sánchez-Jurado, Leonardo Gianluca Lacerenza, Nencioni Cesira, David Caldevilla Bernardo, Antonio Perrella, Laura Niccoli, Lourdes Sáez Méndez, Daniela Matarrese, Delia Goletti, Yee Joo Tan, Vanessa M Monteil, George Dranitsaris, Fabrizio Cantini, Alessio Farcomeni, Shuchismita Dutta, Stephen K Burley, Mirjana Jerkic, Mauro Pistello, William Li, Marta Mas Romero, Fernando Andrés Pretel, Rafaela Sánchez Simón-Talero, Rafael García-Molina, Claudia Kutter, James H Felce, Zehra F Nizami, Andras G Miklosi, Josef M Penninger, Francesco Menichetti, Ali Mirazimi, Pedro Abizanda Soler, Volker Martin Lauschke
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Science advances 7 (1) (2021)
Stelios Chrysostomou, Rajat Roy, Filippo Prischi, Lucksamon Thamlikitkul, Kathryn L Chapman, Uwais Mufti, Robert L Peach, Laifeng Ding, David C Hancock, Christopher Moore, Miriam Molina-Arcas, Francesco Mauri, David James Pinato, Joel M Abrahams, Silvia Ottaviani, Castellano L, Georgios Giamas, Jennifer Pascoe, Devmini Moonamale, Sarah J Pirrie, Claire Gaunt, Lucinda Billingham, Neil M Steven, Michael Cullen, David Hrouda, Mathias Winkler, John Post, Philip Cohen, Seth J Salpeter, Vered Bar, Adi Zundelevich, Shay Golan, Dan Leibovici, Romain Lara, David R Klug, Sophia N Yaliraki, Mauricio Barahona, Yulan Wang, Julian Downward, J Mark Skehel, Maruf M U Ali, Michael J Seckl, Olivier E Pardo
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer. Science translational medicine 13 (602) (2021)
Sladjana Zagorac, Alex de Giorgio, Aleksandra Dabrowska, Mark Kalisz, Nuria Casas-Vila, Paul Cathcart, Angela Yiu, Silvia Ottaviani, Neta Degani, Ylenia Lombardo, Alistair Tweedie, Tracy Nissan, Keith W Vance, Igor Ulitsky, Justin Stebbing, Castellano L
SCIRT lncRNA Restrains Tumorigenesis by Opposing Transcriptional Programs of Tumor-Initiating Cells. Cancer research 81 (3) (2020)
Peter J Richardson, Silvia Ottaviani, Alessandro Prelle, Justin Stebbing, Giacomo Casalini, Mario Corbellino
CNS penetration of potential anti-COVID-19 drugs. Journal of neurology 267 (7) (2020)
Ling Peng, Kui Xiao, Silvia Ottaviani, Justin Stebbing, Ying-Jie Wang
A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib. Expert opinion on drug safety 19 (11) (2020)
Silvia Ottaviani, Justin Stebbing, Adam Enver Frampton, Sladjana Zagorac, Jonathan Krell, Alexander de Giorgio, Sara M Trabulo, Van T M Nguyen, Luca Magnani, Hugang Feng, Elisa Giovannetti, Niccola Funel, Thomas M Gress, Long R Jiao, Ylenia Lombardo, Nicholas R Lemoine, Christopher Heeschen, Castellano L
Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. Nature communications 10 (1) (2019)
Silvia Ottaviani, Justin Stebbing, Adam Enver Frampton, Sladjana Zagorac, Jonathan Krell, Alexander de Giorgio, Sara M Trabulo, Van T M Nguyen, Luca Magnani, Hugang Feng, Elisa Giovannetti, Niccola Funel, Thomas M Gress, Long R Jiao, Ylenia Lombardo, Nicholas R Lemoine, Christopher Heeschen, Castellano L
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. Nature communications 9 (1) (2018)
Hetal Patel, Manikandan Periyasamy, Georgina P Sava, Alexander Bondke, Brian W Slafer, Sebastian H B Kroll, Marion Barbazanges, Richard Starkey, Silvia Ottaviani, Alison Harrod, Eric O Aboagye, Laki Buluwela, Matthew J Fuchter, Anthony G M Barrett, R Charles Coombes, Simak Ali
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment. Molecular cancer therapeutics 17 (6) (2018)
Silvia Ottaviani, Castellano L
microRNAs: Novel regulators of the TGF-β pathway in pancreatic ductal adenocarcinoma. Molecular & cellular oncology 5 (6) (2018)

Silvia Ottaviani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Silvia Ottaviani